Prodrugs for improved oral nalbuphine bioavailability: inter-species differences in the disposition of nalbuphine and its acetylsalicylate and anthranilate esters
- 1 August 1987
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 38 (1-3) , 199-209
- https://doi.org/10.1016/0378-5173(87)90115-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Estimation of area under the curve for drugs subject to enterohepatic cyclingJournal of Pharmacokinetics and Biopharmaceutics, 1985
- The Pharmacokinetics of Heroin in Patients with Chronic PainNew England Journal of Medicine, 1984
- METABOLISM OF METHYLDOPA IN MAN AFTER ORAL-ADMINISTRATION OF THE PIVALOYLOXYETHYL ESTER1984
- Prodrugs of etilefrine: Synthesis and evaluation of 3′-(O-acyl) derivativesJournal of Pharmaceutical Sciences, 1980
- EVALUATION OF SUCCINIMIDOETHYL AND PIVALOYLOXYETHYL ESTERS AS PROGENITORS OF METHYLDOPA IN MAN, RHESUS-MONKEY, DOG, AND RAT1978
- Improved delivery through biological membranes. 4. Prodrugs of L-DOPAJournal of Medicinal Chemistry, 1977
- 1ST-PASS EFFECT OF MORPHINE IN RATS1977
- The metabolism and clinical activity of terbutaline and its prodrug ibuterolEuropean Journal of Clinical Pharmacology, 1976